ããå ç«äžå šãŠã€ã«ã¹ãŸãã¯åã«HIVã¯20äžçŽã®ãã¹ãã§ãã ããªã倧ããªã¿ã€ãã«ã§ããã倧ããã§ã¯ãããŸããã ãã®ç æ°ã¯äœçŸäžäººãã®åœã奪ããŸããã ãããŠæ¯å¹Žããã®æœè¡æ§çŸæ£ã®ç ç²è ã®æ°ãå¢ããŠãããHIVã®æ²»çãšèšºæãç®çãšããç 究ã®æ°ãå¢ããŠããŸãã ããããç æ°ãããã³HIVãäŸå€ã§ã¯ãããŸããããçºéã®åæ段éã§æ²»çããã®ãæãç°¡åã§ãã ããããããã«ã¯ãæåã®çç¶ãçŸããåã§ãã£ãŠããã§ããã ãæ©ããããèªèããæ¹æ³ãå¿ èŠã§ãã ããšãã°ãæãåããšãã«ããã衚瀺ãããŸããã€ãŸããäœãæ²»çããããæ確ã«ããããŸãã HIVã¯ãããèªäœãæããã«ããããšãªããã€ãŸãç¡çç¶ã§ãããªãé·ãéã人äœã«äœãããšãã§ããŸãã ä»æ¥ãç§ãã¡ã¯ã¹ããŒããã©ã³ã«æ¥ç¶ãããå°ããªããã€ã¹ãä»ããŠå ç«äžå šãŠã€ã«ã¹ã®ååšãè¿ éãã€æ£ç¢ºã«å€æã§ããæ°ããçºæãæ€èšããŸãã ãã®ã€ãããŒã·ã§ã³ã¯ã©ã®ããã«æ©èœãããã®çµæã¯ã©ã®çšåºŠæ£ç¢ºã§ãããç 究è ã¯å°æ¥ã©ã®ãããªèšç»ãç«ãŠãŠããŸããïŒ ç§ãã¡ã¯ãç 究ã°ã«ãŒãã®å ±åæžã§ãããã®è³ªåãä»ã®è³ªåã«å¯Ÿããçããæ¢ããŸãã
çè«çæ ¹æ
ç æ°ã«ã€ããŠè©±ãããšã¯äžå¿«ã§ãããå¿ èŠã§ãã 圌ãã«ã€ããŠãã£ãšç¥ãã°ç¥ãã»ã©ãèªåãã¡ãšæãã人ãã¡ã圌ãã®åœ±é¿ããå®ãããšãã§ããŸãã
HIV-ããå ç«äžå šãŠã€ã«ã¹ã¯ãåäžçŽã®80幎代åé ã«ã²ã©ãé¡ãããããŸããã ãããã誰ããããäœã§ããããç¥ããŸããã§ããããããŠããŠã€ã«ã¹èªäœã¯ååããæã£ãŠããŸããã§ããã ãããªãç 究ã«ãããHIVã¯æãéèŠãªã·ã¹ãã ã®1ã€ã§ããäœã®å ç«ç³»ã®çŽ°èã«ææããã¬ãããŠã€ã«ã¹ã§ããããšã瀺ãããŠããŸãã ãŠã€ã«ã¹ã®åãã®çµæã¯ãå ç«é²åŸ¡ã®æå¶ãšãšã€ãºïŒåŸå€©æ§å ç«äžå šçå矀ïŒã®çºçã§ãã ãã®ç¶æ ã§ã¯ã身äœã¯ç¡é²åã®ãŸãŸã§ãããã©ããªè»œåºŠã®ææçïŒããã³ãã现èïŒã§ãäœã«åçãªåœ±é¿ãäžããå¯èœæ§ããããŸãã æ¬è³ªçã«ãHIVã¯ç§ãã¡ã®é²åŸ¡ãç Žå£ããææã«çŽé¢ããæµãå·éã«äœãåŒãç¶ããŸãã
HIVã«ã¯ææã®æ¥è§Šã¡ã«ããºã ããããŸãã ææã¯ãè¡æ¶²ã粟液ãæ¯ä¹³ãåæ皮液ããŸãã¯è£åæ³ç©ãšã®æ¥è§Šã«ãã£ãŠçºçããå¯èœæ§ããããŸãã èšãæããã°ãç¡é²åãªæ§äº€ãææããå»çåšå ·ããããŠã¿ãã¥ãŒããŒã©ãŒã®ææããŠããªãéã§ããããŠã€ã«ã¹ãåºããçŽ æŽãããæ¹æ³ã§ãã HIVã®åºçŸã®æ代ã«ããããã¯ãHIVãäœã§ãããã©ã®ããã«æ¡æ£ãããã«ã€ããŠã®ä¿¡é Œã§ããæ å ±ãããéãéå£ã«åºãã£ããšããææã¯åçŽãªæ¡æã«ãããã®ã§ãããšèããããŠããŸããã ããã¯ç¥è©±ã§ãããªããªãããŠã€ã«ã¹ã¯ææãã人ãšã®ç°¡åãªæ¥è§Šã§ã¯åºãããªãããã§ãã ããããææã®ãã®ãªãã·ã§ã³ãå¯èœã§ãããææè ãšææã®å¯èœæ§ã®ããç ç²è ã®æã«éããå·ãããå Žåã®ã¿ã§ãã HIVãåªä»ããèïŒèãæ£è ã®è¡æ¶²ã飲ã¿ãå¥åº·ãªäººã«åãŸããããã«åœŒã«ææããå¯èœæ§ãããïŒãç¥è©±ã§ããããšããäºå®ã«ã€ããŠã¯è©±ããŠããªãã
äžçä¿å¥æ©é¢ïŒ2017ïŒã«ããäžççãªHIVææçã
ãŠã€ã«ã¹èªäœãšãã®èšºæã®æ°ããæ¹æ³ã«ã€ããŠã¯ããŸãè°è«ããªãã®ã§ããŠã€ã«ã¹ãšäœå ã§ã®ãŠã€ã«ã¹ã®çºéã®çµæã«ã€ããŠã¯è©³ãã説æããŸããã ããããHIVã¯ææãã人ã®äœå ã§æéãšãšãã«å€åããæ£è ãŠã€ã«ã¹ã§ãããããããŸããŸãªå°ã蟌ããæ²»çæ¹æ³ã«å¯ŸããŠããã«æµæåãããããšã«æ³šæããŠãã ããã ããã¯ãã§ããã ãæ©ãæ€åºããå¿ èŠããããã1ã€ã®çç±ã§ãã ãŠã€ã«ã¹ã®æéãé·ãã»ã©ããŠã€ã«ã¹ã¯åŒ·ããªããææè ã¯åŒ±ããªããŸãã
ããã€ã¹ã¯äœã§æ§æãããŠããŸããïŒ
ãã®ç 究ã«é¢ä¿ããç§åŠè ã¯ãäžçã®ä»ã®ç æ°ãšåæ§ã«ãHIVã®æ©æ蚺æã«ãããæãæ·±å»ãªåé¡ãšéå£ã®1ã€ã¯ãå®éšå®€ã人å¡ãå»çæœèšãªã©ã®é©åãªæ¡ä»¶ã®æ¬ åŠã§ãããšèšããŸãã ãã®ããã圌ãã¯äœå ã«ãŠã€ã«ã¹ããããã©ãããæ£ç¢ºã«ç€ºãããšãã§ããããã€ã¹ãäœæããããšã«ããŸããã è¡ç³å€ã¯ãããŒã¿ãã«ã³ã³ãã¯ãããã€ã¹ïŒã°ã«ã³ã¡ãŒã¿ïŒã䜿çšããŠãã€ãŸããç 究宀ã蚪ããŠæ°æ¥éãã¹ãçµæãåŸ ã€å¿ èŠãªããé·æéã«ããã£ãŠãã§ã«ãã§ãã¯ã§ããŸãã ãã®ãããªããã€ã¹ã®ã³ã¹ãã¯éåžžã«äœãããã®é åžã«ã䌎ããŸãã
ä»æ¥ç¥ãããããã€ã¹ã¯ã以äžã®ããã«ç°¡åã«èª¬æã§ããŸãïŒã«ãŒãçæž©å¢å¹ ïŒLAMPïŒããã³ããã¢ãŒã¿ãŒïŒCALMïŒã«åºã¥ãHIV-1ã®åå決å®ã®ããã®ã¢ãã€ã«ã¢ãã©ã€ã¶ãŒã ãããŠä»ãé çªã«ã
ããã¢ãŒã¿ãŒ
ããã¢ãŒã¿ãŒïŒãã€ã¯ãã¢ãŒã¿ãŒãšãåŒã°ããŸãïŒã¯ãéåäžã®ãšãã«ã®ãŒãå€æã§ãã埮èŠçååããã€ã¹ãšåŒã°ããŸãã ããããç¹å®ã®ååŠæº¶æ¶²ã«å ¥ããããå Žåããããã¯ç¹å®ã®ã«ãŒãã«æ²¿ã£ãŠç¬ç«ããŠåãå§ããŸããããã¯ã蚺æãããã«ã¯ãããã¯ãããžãŒæ©åšã®ãšãã«ã®ãŒäŸçµŠã«äœ¿çšã§ããŸãã
HIVãã¹ã¿ãŒã®ãã€ã¯ãã¢ãŒã¿ãŒåœ¢æã¹ããŒã ã
ãã€ã¯ãã¢ãŒã¿ãŒã¯ãå¯åºŠã1.04 g / cmã®PtïŒãã©ããïŒããç²åã§ã³ãŒãã£ã³ã°ãããããªã¹ãã¬ã³è£œã®çäœã§ãã ããã«ãAuïŒéïŒããç²åã¯ããã€ã¯ããããŒããDNAãããŒãã§ä¿®é£Ÿããããã«ã䜿çšãããŸããïŒäžã®å³ã§ã¯ãèµ€ãã觊æããšããŠè¡šç€ºãããŠããŸãïŒã
TEMïŒééåé»åé¡åŸ®é¡ïŒã¯ããã€ã¯ãã¢ãŒã¿ãŒã®ã³ãŒãã£ã³ã°ã«äœ¿çšãããçœéãšéã®ããç²åãç圢ã§ãããçŽåŸã57.721±5.181 nmïŒPtïŒããã³3.4ââ3±1.336 nmïŒAuïŒã§ããããšã瀺ããŸããã
äžèšã¯ãTEMç»åãããç²åã調補ããåçãã©ã¹ã³ãããã³å åŠåå æ³ã®çµæã§ãã
å®å šã«åœ¢æããããã€ã¯ãã¢ãŒã¿ãŒã®DNAãããŒããã©ã®çšåºŠå¹ççã«DNAååãææã§ãããã確èªããå¿ èŠããããŸããã ãã®ããã«ã ã¢ã¬ããŒã¹* ïŒC 12 H 18 O 9 ïŒã²ã«é»æ°æ³³åæ³ã䜿çšããŸããã
ã¢ã¬ããŒã¹*ã¯ã1â4çµåã§çµåããäžé£ã®Î²-D-ã¬ã©ã¯ããã©ããŒã¹æ®åºãš3,6-ç¡æ°Žç©-α-L-ã¬ã©ã¯ããã©ããŒã¹ã«ãã£ãŠåœ¢æãããç·ç¶å€ç³ã§ãã å¯å€©ããå ¥æã
ãã®ææ³ã«ããããã€ã¯ãã¢ãŒã¿ãŒã®è¡šé¢ã«DNAãããŒããããããšã確èªã§ããŸãããããã¯ãçŽ180 bpã®äººå·¥DNAååïŒå¯Ÿã«ãªã£ãå¡©åºïŒãçµåã§ããããã§ãïŒãã®ãããªïŒäººå·¥ã®ïŒãµã³ãã«ã§ã¯åªããçµæã§ãïŒå·Šã®ç»åïŒïŒã æåã®ãã¹ãäžã®ææå¹çã®çšåºŠã¯çŽ30ïŒ ã§ãããããã¯èå åæã«ãã£ãŠç¢ºèªãããŸããïŒå·Šã®ç»åïŒã
ããã§ã¯ãããŸããŸãªæ¿åºŠã®H 2 O 2 ïŒ0ã5ã10ãããã³15ïŒ ïŒã®æº¶æ¶²äžã§ãã€ã¯ãã¢ãŒã¿ãŒãã©ã®ããã«åããã確èªããŸãã
ãŸãããã€ã¯ãã¢ãŒã¿ãŒã®æãéèŠãªæ©èœã§ããåãã確èªããå¿ èŠããããŸããã ãã®ããã«ãH 2 O 2ãå«ã溶液ãšå«ãŸãªã溶液ã䜿çšããŸãã ïŒäžã®ç»ådã®è»è·¡ã®æ¯èŒïŒã éé žåæ°ŽçŽ ãååšããªããšããã€ã¯ãã¢ãŒã¿ãŒãæ¯åããŸããããããã¯ãã©ãŠã³éåã«ãããã®ã§ãã H 2 O 2ã溶液ã«å°å ¥ããå§ãããšãããã€ã¯ãã¢ãŒã¿ãŒã®é床ã¯ã溶液äžã®1ïŒ éé žåæ°ŽçŽ ããšã«çŽ0.7ÎŒm/ så¢å ããŸããã
è©Šéšæº¶æ¶²äžã®ãã€ã¯ãã¢ãŒã¿ãŒã®é床ã®æž¬å®ã
å³aã¯ãçŽåŸ6ÎŒmã®ãã€ã¯ãã¢ãŒã¿ãŒã®é床ãšæº¶æ¶²äžã®H 2 O 2ã®æ¿åºŠã®äŸåæ§ã瀺ããŠããŸãã ãŸããïŒå³åŽïŒã¯ããã€ã¯ãã¢ãŒã¿ãŒãšãã®è»è·¡ã®ã¹ãããã·ã§ããã§ãã å³bã¯ã5ïŒ éé žåæ°ŽçŽ æº¶æ¶²ã«ãããããŸããŸãªæž©åºŠã§ã®ãã€ã¯ãã¢ãŒã¿ãŒã®å®å®åºŠã瀺ããŠããŸãã 以äžïŒã°ã©ããšã¹ãããã·ã§ããïŒã«ãå®å®æ§ã€ã³ãžã±ãŒã¿ãŒãæéïŒ120ç§ïŒãšãšãã«ã©ã®ããã«å€åããããããã³15ïŒ ã®ãœãªã¥ãŒã·ã§ã³ã§æ¢ã«ç§»åããŠããè»è·¡ã瀺ããŸãã æéã«å¯Ÿããäºä¹å¹³åå¹³æ¹æ ¹å€äœãã°ã©ãeã«ç€ºããŸããé»ãç¹-H 2 O 2ã®ãªã溶液ãèµ€-5ïŒ H 2 O 2
以äžã®ç»åfã§ã¯ããã€ã¯ãã¢ãŒã¿ãŒãé 眮ãããŠãããœãªã¥ãŒã·ã§ã³ã®ç¶æ ããã®åäœã«åœ±é¿ããã ãã§ãªãããã€ã¯ãã¢ãŒã¿ãŒèªäœãããæ£ç¢ºã«ã¯ãã®æ§é ã倧ããå€åããŠããããšãããããŸãã çŽåŸ6ÎŒmã®æ¬æ Œçãªãã¹ãæžã¿ãã€ã¯ãã¢ãŒã¿ãŒïŒèµ€ç·ïŒãšæ¯èŒããŠããã©ãããšéããã®ã¹ãã¬ãŒãªãã§çŽåŸ3ÎŒmã®ãã€ã¯ãã¢ãŒã¿ãŒãã©ã®ããã«åããïŒéç·ïŒã確èªããŸãã è»è·¡ã®æ¯èŒã®å³åŽã«ã¯ããã€ã¯ãã¢ãŒã¿ãŒã®å¹³åäºä¹å€äœã®æ¯èŒããããŸãïŒçŽåŸ3ÎŒmãš6ÎŒmïŒã
ã¢ãã€ã«æ©åš
Motorola XT1575ïŒAndroid OSïŒã¯ããã€ã¯ãã¢ãŒã¿ãŒã®èŠèŠåãšè¿œè·¡ïŒã€ãŸãã蚺æã®çºçç¶æ³ã®ç£èŠïŒã«äœ¿çšãããŸããã
ããã€ã¹ã®å€èŠ³ãšè©³çŽ°ã
ããã€ã¹ã®éèŠãªã³ã³ããŒãã³ãã¯ããã€ã¯ãã¢ãŒã¿ãŒã®åãã確èªããããã«å¿ èŠãªãããã§ãã ããªã¡ãã«ã¡ã¿ã¯ãªã¬ãŒãïŒãã¬ãã·ã°ã©ã¹ïŒã§ã§ããŠããŸããã 80 mmã®æ¥çå€å±€ã䜿çšããŠãå¹ 2 mmã®ã¬ãŒã¶ãŒã«ããããã£ãã«ããåããã¬ã©ã¹ããŒã¹ãåãä»ããŸããã
ãããã®å€èŠ³ãšå¯žæ³ã
äžã®åçãããããããã«ãããã€ã¹ã®äžéšã¯ãããã ãã§ã¯ãããŸããã éãåãå€ãå¯èœãªã±ãŒã¹ã¯ã3Dããªã³ã¿ãŒã§å®äŸ¡ãªçŽ æã§äœãããŠããŸããã ãã®ã±ãŒã¹ã®äžã«ã¯ãçœè²LEDã3.3 VããããªãŒãã¹ã€ãããå®äŸ¡ãªå åŠã¬ã³ãºããããŸãã ãŸããã¬ã³ãºãšæºåž¯é»è©±ã®ã«ã¡ã©ã®éã«ãµã³ãã«ã眮ãããšãã§ãããµã³ãã«ãã«ããŒããããŸãã
ãããŠä»ããœãããŠã§ã¢ã³ã³ããŒãã³ãã«ã€ããŠã ãœãããŠã§ã¢ã¯ãOpenCV 3.1.0ã©ã€ãã©ãªã䜿çšããŠAndroid Studioã§äœæãããŸããã ç§åŠè ã«ãããšãã€ã³ã¿ãŒãã§ãŒã¹ã¯ãŠãŒã¶ãŒã«ãšã£ãŠå¯èœãªéãæ確ã§å®çšçã§ãã
HIVãã¹ã¿ãŒã€ã³ã¿ãŒãã§ã€ã¹ã
ãµã³ãã«ãããã€ã¹ã«é 眮ããããšãããã°ã©ã ã¯ãããªïŒ30 fpsã320x240ãã¯ã»ã«ïŒãèšé²ããŸãããã®ãããªã¯ããã€ã¯ãã¢ãŒã¿ãŒã®åãã瀺ãããã®åãã®é床ãèšç®ãã1å以å ã«åæçµæã瀺ããŸãã
ã«ãŒãçæž©å¢å¹ ïŒLAMPïŒ
HIV-1ã®èªèã«ããããã€ã¯ãã¢ãŒã¿ãŒã·ã¹ãã ã®å¹æã¯ã©ããããã§ããïŒ ãã®è³ªåã«å¯Ÿããçãã¯ãLAMPåå¿ã«ãããŸãã ãã¹ãã®ããã«ãç°ãªãæ¿åºŠã®HIV-1 RNAïŒãªãæ žé žïŒã§ããã€ãã®ãµã³ãã«ã調補ããŸããã å¢å¹ çµæãã¢ã¬ããŒã¹ã²ã«é»æ°æ³³åã§è©äŸ¡ããŸããã
LAMPãã¹ãã
é»æ°æ³³åã®çµæã¯ã倧ããªDNAã¢ã³ããªã³ã³ã®æ®µéçãªåœ¢æã瀺ããïŒDNAé åãå¢å¹ çµæïŒã ã¢ã³ããªã³ã³ã®æ°ã¯ãHIV-1 RNAã®æ¿åºŠã«æ¯äŸããŸããã
ãã€ã¯ãã¢ãŒã¿ãŒã¯HIV-1 RNAã¢ã³ããªã³ã³ãšæ··åããããã€ããªãã€ãŒãŒã·ã§ã³ããã»ã¹ïŒæž©åºŠ80âïŒãåããããšãå¯èœã«ãªããŸããã 次ã«ãåŸããããæ··åç©ããH 2 O 2ã® 5ïŒ æº¶æ¶²ã§ãã¹ãããŸããã HIV-1 RNAã®ã¢ã³ããªã³ã³ãã·ã¹ãã ã«ååšãããšããã€ã¯ãã¢ãŒã¿ãŒã®é床ã¯çŽ95.26ïŒ äœäžããŸããã äœæ¿åºŠã®ã¢ã³ããªã³ã³ïŒçŽ3.394±0.245 ng /ÎŒlïŒã§ãé床ã®äœäžã芳å¯ãããŸãã
HIV-1 RNAã®éååšäžã§ã®åŸ®å°éåã®å®èšŒã
HIV-1 RNAã®ååšäžã§ã®åŸ®å°éåã®å®èšŒã
ç§åŠè ã¯ãŸãããã€ã¯ãã¢ãŒã¿ãŒãšãã®é床ãå埩ããããšã«æåããŸããã ãã®ããã«ããã€ã¯ãã¢ãŒã¿ãŒãšã¢ã³ããªã³ã³ãå«ããææããããµã³ãã«ã90âã®æž©åºŠã§30ç§éã€ã³ãã¥ããŒãããŸããã ããã«ããããã€ã¯ãã¢ãŒã¿ãŒDNAãããŒãããã¢ã³ããªã³ã³ã解æŸããããšãå¯èœã«ãªããŸããã ãã®åŸã6000 x gã§5åéé å¿åé¢ããŸããã H 2 O 2ã® 5ïŒ æº¶æ¶²ã§åŸããããµã³ãã«ã®æ€èšŒã«ãããHIV-1 RNAã¢ã³ããªã³ã³ã䜿çšããŠãã¹ãããåã«ããã€ã¯ãã¢ãŒã¿ãŒã®é床ãåæé床ã®75.52ïŒ ã®ã¬ãã«ã«å埩ããããšã瀺ãããŸããã
Cåããã³Båèçããã«ãã¹ãããããŒããŠã€ã«ã¹16ïŒHPV-16ïŒãªã©ãä»ã®ã¿ã€ãã®æ§ææãŠã€ã«ã¹ã«å¯Ÿããã·ã¹ãã ã®åå¿ããã¹ããããŸããã HIVãšäžèšã®ãŠã€ã«ã¹ã®ããã€ãã«äžŠè¡ææãé »ç¹ã«èµ·ããããããã®ãã¹ããéåžžã«éèŠã§ããã çµæã¯æºè¶³ã®ãããã®ã§ãã-DNAã¢ã³ããªã³ã³ã¯HIVã®ååšäžã§ã®ã¿åœ¢æãããŸããã ã€ãŸãããã¹ããµã³ãã«ã«ä»ã®ãŠã€ã«ã¹ãååšããŠãããã§ãã¯ããã»ã¹ã«åœ±é¿ã¯ãããŸããã§ããã
çµè«ã¯ç°¡åã§ã-ã¡ãœããã¯HIVã®ååšãå€æã§ããŸãã ããããã·ã¹ãã ããµã³ãã«äžã®ãŠã€ã«ã¹ã®æç¡ãåºå¥ã§ããããã«ãæšæºæ¿åºŠã®1000ç²å/ mlã«çŠç¹ãåãããŠããã£ãªãã¬ãŒã·ã§ã³ãå®è¡ããå¿ èŠããããŸãã æ¿åºŠããã®ææšããäœãå Žåãçµæã¯é°æ§ïŒãŠã€ã«ã¹ãååšããªãïŒã§ãããæ¿åºŠãé«ãå Žåãçµæã¯éœæ§ã§ãã ãã£ãªãã¬ãŒã·ã§ã³ãå®è¡ããã«ã¯ããã€ã¯ãã¢ãŒã¿ãŒã®é床ãæ¿åºŠã«å¯Ÿå¿ãããã©ãããå€æããå¿ èŠããããŸããã ãã®ããã«ãPBS-ç 究çšã®ç¹å¥ãªæº¶æ¶²ã§ãããªã³é žãããªãŠã ç·©è¡æ¶²ãšHIVã®æç¡ã«ãããããæ£è ã®è¡æŒ¿ã䜿çšããŸããã
åæå®å®åHIV-1 RNAã®æ¿åºŠã0ã107ã®ç¯å²ã§ããPBSã䜿çšããŠããã£ãªãã¬ãŒã·ã§ã³ãå®è¡ããŸããã
ãã£ãªãã¬ãŒã·ã§ã³åŸãHIVæ¿åºŠ1000ã§ã®å¹³åãã€ã¯ãã¢ãŒã¿ãŒé床ã¯0.705±0.082ÎŒm/ sã§ããããšãæããã«ãªããŸããã
HIV-1 RNAã®æ¿åºŠã決å®ããçµæã
ç§åŠè ã¯ROCæ²ç·ã䜿çšããŠã·ã¹ãã ãåæããéåžžã«ææãªçµæã瀺ããŸããã ãã¹ããããã·ã¹ãã ã®æ床*ã¯ã CI * 81.8ã99.3ïŒ ã§çŽ94.6ïŒ ã ç¹ç°åºŠ* 80.5ã100ïŒ ã®CIã§99.1ïŒ ã§ããã
æ床* -è¯å®çãªçµæã®å²åãåæ ããææšïŒãã®å Žåããµã³ãã«äžã®HIVæ¿åºŠã1000ãè¶ ãã確çã§ãïŒãã·ã¹ãã çµæã®æ£åžå³ãä¿¡ããããªãã»ã©ã®çµæã瀺ããŸããã ãããã£ãŠãHIVæ¿åºŠãé«ããµã³ãã«ãéœæ§ãšå€å®ãã粟床ã¯100ïŒ ã§ãããé°æ§ãµã³ãã«ãå€å®ãã粟床ã¯90ïŒ ã§ãã
ç¹ç°æ§*ã¯ãé°æ§çµæã®å²åãåæ ããææšã§ãïŒãã®å Žåããµã³ãã«äžã®HIVæ¿åºŠã1000æªæºã§ãã確çã§ãïŒã
DI * -ä¿¡é Œåºéãã€ãŸããç¹å®ã®ä¿¡é Œæ§ãæã€æªç¥ã®ãã©ã¡ãŒã¿ãŒãã«ããŒããåºéã
ãããªçŽ æïŒ
HIV-1 RNAæ¿åºŠããããå€ãè¶ ããå Žåã®ãã€ã¯ãã¢ãŒã¿ãŒã®åãã瀺ããããªïŒéœæ§ãµã³ãã«ïŒã
HIV-1 RNAã®æ¿åºŠããããå€ãäžåã£ãå Žåã®ãã€ã¯ãã¢ãŒã¿ãŒã®åãã瀺ããããªïŒãã¬ãã£ããµã³ãã«ïŒã
HIV-1 RNAæ¿åºŠããããå€ãè¶ ããå Žåã®ãã€ã¯ãã¢ãŒã¿ãŒã®åãã瀺ããããªïŒéœæ§ãµã³ãã«ïŒã
HIV-1 RNAã®æ¿åºŠããããå€ãäžåã£ãå Žåã®ãã€ã¯ãã¢ãŒã¿ãŒã®åãã瀺ããããªïŒãã¬ãã£ããµã³ãã«ïŒã
ãã®ç 究ããã詳现ã«ç解ããã人ã¯ãç§åŠè ã®å ±åãšããã«è¿œå ãããè³æã調ã¹ãããšãã§ããŸãã
ãšãããŒã°
ãã®é©ãã¹ãããã€ã¹ãäœæããç§åŠè ã¯ããŸã å€ãã®ãã¹ãããã£ãªãã¬ãŒã·ã§ã³ãæ¹åãå®æœããŠããªãããšãåŠå®ããŠããŸããã ãããããããã¯æããã«æ£ããè»éã«ä¹ã£ãŠããŸãã ãã®ãããªããã€ã¹ã¯ãç¹ã«ã¹ã¿ãããšå€æ°ã®å»çæ©åšãåããç 究æãå©çšã§ããªãå Žæã«ãã人ã ã®éã§ãHIVã®spread延ãå€§å¹ ã«æžããããšãã§ããŸãã
ã¯ããããã€ã¹ã¯ãŸã éåžžã«ã³ã³ãã¯ãã«èŠãããã¹ããŒããã©ã³ã䜿çšããå¿ èŠããããšããäºå®ã¯ã誰ããè¿œãæãå¯èœæ§ããããŸãã ããããå°æ¥çã«ã¯ãHIVã®æ©æ蚺æã®ããã®ãã®ãããªæè¡ã¯ãå¹çãšç²ŸåºŠã ãã§ãªããå©äŸ¿æ§ãšæé ãªäŸ¡æ Œã®é¢ã§ãæ¹åããç¶ããã§ãããã
ãã®è©±ã®åé ã§æžããããã«ãHIVã¯20äžçŽã®ç«ç ã§ãã ããããæ®å¿µãªããããã®ãŠã€ã«ã¹ã¯ãXXIäžçŽã®ãã¹ãããšããã¿ã€ãã«ããããã»ã©é ãã¯ãããŸããã ä»æ¥ãããã€ãã®ç æ°ã¯ãã§ã«ãã®ãããªå€§ããªã¿ã€ãã«ã䞻匵ããŠããŸãïŒäŸãã°ããã€ç ãç³å°¿ç ãªã©ïŒã ãããŠããããã®ç æ°ã®ããããã¯å€§ããªæ³šæãå¿ èŠãšããŸãã ãŸããç æ°ãæ²»ãéæ³ã®è¬ã¯ãããŸããããå©çšå¯èœãªèšºææ¹æ³ãæ¹åããããšããã§ããŸãããããã«ãããæ²»çãæ€çŽ¢ããããç æ°ãå°ã蟌ãããããæéãå¢ããŸãã 圌ããèšãããã«ãåé¡ãæ©ãç¥ãã»ã©ãããã解決ããæ©äŒãå¢ããŸãã
ãã1ã€ã®éèŠãªãã€ã³ãã¯ã瀟äŒæŽ»åããªãŒãã³æ§ãè°è«ã§ãã åé¡ã«ã€ããŠè©±ãåãã¹ãã§ããããã«ã€ããŠè©±ãã®ãæãå Žåã§ãã瀟äŒã¯ã©ã®ããã«ãããšæŠãã€ããã§ããïŒ
ãããã«ãããããã¯ç§ã«ãšã£ãŠãã¹ãŠã§ãã èªåãšæãã人ã®äžè©±ãããŸãã
ãæ»åšããã ãããããšãããããŸãã ç§ãã¡ã®èšäºã奜ãã§ããïŒ ããèå³æ·±ãè³æãèŠããã§ããïŒ æ³šæããããå人ã«æšèŠããããšã§ãç§ãã¡ããµããŒãããŸããç§ãã¡ãããªãã®ããã«çºæãããšã³ããªãŒã¬ãã«ã®ãµãŒããŒã®ãŠããŒã¯ãªã¢ããã°ã®HabrãŠãŒã¶ãŒã®ããã«30ïŒ ã®å²åŒïŒ VPSïŒKVMïŒE5-2650 v4ïŒ6ã³ã¢ïŒã«ã€ããŠã®çå®20ãã«ãŸãã¯ãµãŒããŒãåå²ããæ¹æ³ïŒ ïŒãªãã·ã§ã³ã¯RAID1ããã³RAID10ãæ倧24ã³ã¢ãæ倧40GB DDR4ã§å©çšå¯èœã§ãïŒã
VPSïŒKVMïŒE5-2650 v4ïŒ6ã³ã¢ïŒ10GB DDR4 240GB SSD 1GbpsãŸã§ 6ãæã®æéãæ¯æãå Žåã¯12æãŸã§ç¡æ㧠ã ããã§æ³šæã§ããŸã ã
Dell R730xdã¯2åå®ãã§ããïŒ ãªã©ã³ããšç±³åœã§249ãã«ããIntel Dodeca-Core Xeon E5-2650v4 128GB DDR4 6x480GB SSD 1Gbps 100 TVã2å°æã£ãŠããã ãã§ãïŒ ã€ã³ãã©ã¹ãã©ã¯ãã£ãã«ã®æ§ç¯æ¹æ³ã«ã€ããŠèªãã§ãã ããã ã¯ã©ã¹Rã¯ã1ç±³ãã«ã§9,000ãŠãŒãã®Dell R730xd E5-2650 v4ãµãŒããŒã䜿çšããŠããŸããïŒ